PRC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance
Normal-vs-Primary 1.012570E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Stage1
3.617800E-01
Normal-vs-Stage2
1.55676999999965E-05
Normal-vs-Stage3
4.442400E-01
Normal-vs-Stage4
3.449800E-01
Stage1-vs-Stage2
3.800600E-01
Stage1-vs-Stage3
6.945400E-01
Stage1-vs-Stage4
9.388600E-01
Stage2-vs-Stage3
2.968400E-01
Stage2-vs-Stage4
4.316600E-01
Stage3-vs-Stage4
7.464600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Caucasian
2.18829999999448E-05
Normal-vs-AfricanAmerican
2.399400E-01
Normal-vs-Asian
2.722400E-02
Caucasian-vs-AfricanAmerican
4.488000E-01
Caucasian-vs-Asian
7.185000E-01
AfricanAmerican-vs-Asian
5.834400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Male
2.07969999999058E-05
Normal-vs-Female
1.66207999999779E-05
Male-vs-Female
7.655000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Age(21-40Yrs)
6.018200E-01
Normal-vs-Age(41-60Yrs)
1.99394999998992E-05
Normal-vs-Age(61-80Yrs)
1.483770E-01
Normal-vs-Age(81-100Yrs)
1.716260E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.942800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.783000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.999600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.378000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.295800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.854000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Non Drinker
7.780100E-04
Normal-vs-Daily Drinker
5.222100E-03
Normal-vs-Weekly Drinker
2.553600E-02
Normal-vs-Occasional Drinker
3.601300E-03
Normal-vs-Social Drinker
9.812000E-02
Non Drinker-vs-Daily Drinker
6.005400E-01
Non Drinker-vs-Weekly Drinker
7.789400E-01
Non Drinker-vs-Occasional Drinker
7.298200E-01
Non Drinker-vs-Social Drinker
5.891400E-01
Daily Drinker-vs-Weekly Drinker
4.930800E-01
Daily Drinker-vs-Occasional Drinker
8.655200E-01
Daily Drinker-vs-Social Drinker
9.690800E-01
Weekly Drinker-vs-Occasional Drinker
5.845400E-01
Weekly Drinker-vs-Social Drinker
5.313000E-01
Occasional Drinker-vs-Social Drinker
8.878600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions
Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade)
Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Grade 1
6.080600E-01
Normal-vs-Grade 2
6.979800E-01
Normal-vs-Grade 3
7.306000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.016300E-04
Grade 1-vs-Grade 3
6.32320000000242E-05
Grade 1-vs-Grade 4
6.080600E-01
Grade 2-vs-Grade 3
3.350600E-01
Grade 2-vs-Grade 4
6.979800E-01
Grade 3-vs-Grade 4
7.306000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Diabetic
1.616630E-03
Normal-vs-NonDiabetic
2.70020000003868E-06
Diabetic-vs-NonDiabetic
2.238600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Pancreatitis
2.061700E-02
Normal-vs-NoPancreatitis
2.1618000000001E-05
Pancreatitis-vs-NoPancreatitis
2.257000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions
N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes
N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-N0
1.262170E-01
Normal-vs-N1
3.05079999995961E-06
N0-vs-N1
2.907000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-TP53-Mutant
8.01270161332468E-11
Normal-vs-TP53-NonMutant
1.366460E-04
TP53-Mutant-vs-TP53-NonMutant
1.69505999999542E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap